Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protopic Ointment in Deep Partial-Thickness Burns
NCT05856994Phase 1Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Sep 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Envarsus XR in burn injury (3 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Time to complete wound healing at 21 days. Started Sep 2024; status: terminated.
02
Drugs
Envarsus XR
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT05856994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05856994.